News and Updates

From March 15–18, more than 200 passionate, motivated Breakthrough T1D Advocates from all 50 states convened in Washington, D.C., for Breakthrough T1D 2026 Government Day. Government Day remains one of Breakthrough T1D’s most impactful ways to effect change. By bringing the lived type 1 diabetes (T1D) experience directly to policymakers, we are accelerating progress toward […]

Tzield is the first approved disease-modifying therapy for type 1 diabetes, but Breakthrough T1D will make sure it’s not the last.

Congress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment in type 1 diabetes (T1D) research. The President signed the legislation and it is now law, ensuring continued momentum toward better treatments, disease-modifying therapies, and cures. This legislation: These are huge wins for the T1D community […]

What is the pipeline? Every new medical device, therapy, treatment, and drug—including those for type 1 diabetes (T1D)—goes through the drug development pipeline. Getting a new therapy or device from the earliest stages of research eventually into the hands of people with T1D is a complicated process. Science takes time (from years to decades!), money […]

Analysis compiled by Avalere Health and supported by Breakthrough T1D (formerly JDRF) finds that research funded by the Special Diabetes Program (SDP) has yielded more than $50 billion in federal healthcare savings.  Created by Congress in 1997 and administered by the National Institutes of Health (NIH), the SDP provides federal funding to support research to prevent, treat, and […]

Breakthrough T1D headed to Washington D.C. where advocates held nearly 500 meetings with Members of Congress on behalf of the T1D community.

Breakthrough T1D Chief Global Advocacy Officer Lynn Starr discusses how type 1 diabetes advocacy drives our mission progress forward...faster.

With the support of our grassroots advocates, our work helps advance treatments, influence policy, and improve access to care for those worldwide who need it.

Our Advocates traveled to D.C. to reintroduce our organization and champion legislation and policy for the T1D community.

Breakthrough T1D advocate Natalie Stanback knows type 1 diabetes and knows how to get things done on Capitol Hill. She encourages more women to get involved in advocacy.